Cullinan Therapeutics, Inc.
CGEM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789972
In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Cullinan Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 153
- +11 vs. Q3 2025
- Shares held
- 63.2M
- +2.36M (+3.9%) vs. Q3 2025
- Total value
- $653.8M
- +$293.2M (+81.3%) vs. Q3 2025
- New holders
- 29
- 66 more added
- Sold out
- 18
- 41 more reduced
3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CGEM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 183 | $1.30B |
| Q1 2026 | 174 | $931.0M |
| Q4 2025 | 153 | $653.8M |
| Q3 2025 | 145 | $362.2M |
| Q2 2025 | 144 | $471.4M |
| Q1 2025 | 149 | $489.6M |
| Q4 2024 | 147 | $798.8M |
| Q3 2024 | 137 | $1.09B |
| Q2 2024 | 135 | $1.10B |
| Q1 2024 | 113 | $670.8M |
| Q4 2023 | 113 | $375.6M |
| Q3 2023 | 106 | $344.0M |
| Q2 2023 | 106 | $397.3M |
| Q1 2023 | 103 | $329.5M |
| Q4 2022 | 97 | $397.7M |
| Q3 2022 | 100 | $474.7M |
| Q2 2022 | 89 | $481.7M |
| Q1 2022 | 82 | $386.3M |
| Q4 2021 | 75 | $559.7M |
| Q3 2021 | 66 | $762.3M |
| Q2 2021 | 71 | $828.5M |
| Q1 2021 | 70 | $1.30B |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Cullinan Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| XTX Topco Ltd | 121,257 | $1.26M | 0.03% | −46,722−27.8% | Reduced |
| Two Sigma Advisers, LP | 129,809 | $1.34M | 0.00% | +92,509+248.0% | Added |
| Invesco Ltd. | 130,323 | $1.35M | 0.00% | +28,011+27.4% | Added |
| American Century Companies Inc | 142,761 | $1.48M | 0.00% | +1,692+1.2% | Added |
| Bank of New York Mellon Corp | 144,927 | $1.50M | 0.00% | −4,998−3.3% | Reduced |
| JPMorgan Chase & Co | 147,055 | $1.52M | 0.00% | +115,187+361.5% | Added |
| Assenagon Asset Management S.A. | 158,753 | $1.64M | 0.00% | −18,932−10.7% | Reduced |
| Wellington Management Group LLP | 159,751 | $1.65M | 0.00% | −8,380−5.0% | Reduced |
| Algert Global LLC | 162,501 | $1.68M | 0.03% | −73,591−31.2% | Reduced |
| Jane Street Group, LLC | 186,844 | $1.93M | 0.00% | −114,041−37.9% | Reduced |
| PFM Health Sciences, LP | 227,003 | $2.35M | 0.24% | +227,003 | New |
| Susquehanna Portfolio Strategies, LLC | 233,842 | $2.42M | 0.04% | +109,311+87.8% | Added |
| Citigroup Inc | 240,457 | $2.49M | 0.00% | +133,282+124.4% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 244,022 | $2.53M | 0.01% | +104,998+75.5% | Added |
| Barclays PLC | 269,655 | $2.79M | 0.00% | +18,545+7.4% | Added |
| OrbiMed Advisors LLC | 270,006 | $2.79M | 0.06% | −1,653,849−86.0% | Reduced |
| UBS Group AG | 271,736 | $2.81M | 0.00% | +83,551+44.4% | Added |
| AQR Capital Management LLC | 281,483 | $2.91M | 0.00% | +83,563+42.2% | Added |
| Elmind Capital, LP | 310,000 | $3.21M | 0.95% | +310,000 | New |
| Schroder Investment Management Group | 343,667 | $3.41M | 0.00% | +343,667 | New |
| Bank of America Corp | 346,307 | $3.58M | 0.00% | −210,882−37.8% | Reduced |
| Point72 Asset Management, L.P. | 360,162 | $3.73M | 0.01% | +360,162 | New |
| Millennium Management LLC | 362,495 | $3.75M | 0.00% | −187,976−34.1% | Reduced |
| Jump Financial, LLC | 364,889 | $3.78M | 0.05% | +170,382+87.6% | Added |
| Trexquant Investment LP | 381,535 | $3.95M | 0.04% | +193,917+103.4% | Added |
| Deerfield Management Company, L.P. (Series C) | 386,169 | $4.00M | 0.05% | −2,540,844−86.8% | Reduced |
| Marshall Wace, LLP | 414,359 | $4.29M | 0.00% | +118,917+40.3% | Added |
| Northern Trust Corp | 421,635 | $4.36M | 0.00% | −25,632−5.7% | Reduced |
| Charles Schwab Investment Management Inc | 436,273 | $4.52M | 0.00% | +33,635+8.4% | Added |
| Two Sigma Investments, LP | 470,526 | $4.87M | 0.01% | +410,854+688.5% | Added |
| Nuveen, LLC | 579,095 | $5.99M | 0.00% | +363,500+168.6% | Added |
| Deutsche Bank AG | 586,636 | $6.07M | 0.00% | +14,898+2.6% | Added |
| Twin Focus Capital Partners, LLC | 595,489 | $6.16M | 0.71% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 631,706 | $6.54M | 0.01% | +102,298+19.3% | Added |
| Great Point Partners LLC | 634,032 | $6.56M | 2.13% | +634,032 | New |
| Goldman Sachs Group Inc | 721,864 | $7.47M | 0.00% | −262,096−26.6% | Reduced |
| Morgan Stanley | 766,934 | $7.94M | 0.00% | +366,780+91.7% | Added |
| Dimensional Fund Advisors LP | 848,769 | $8.78M | 0.00% | −335,052−28.3% | Reduced |
| Nextech Invest, Ltd. | 1,141,145 | $11.8M | 1.14% | 00.0% | Unchanged |
| Siren, L.L.C. | 1,193,410 | $12.4M | 0.37% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 1,237,043 | $12.8M | 0.34% | +1,237,043 | New |
| Geode Capital Management, LLC | 1,302,262 | $13.5M | 0.00% | +6,942+0.5% | Added |
| VR Adviser, LLC | 1,379,965 | $14.3M | 0.71% | 00.0% | Unchanged |
| RTW Investments, LP | 1,705,960 | $17.7M | 0.18% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 1,932,106 | $20.0M | 1.44% | +1,668,289+632.4% | Added |
| State Street Corp | 2,197,338 | $22.7M | 0.00% | +520,024+31.0% | Added |
| Blue Owl Capital Holdings LP | 2,350,972 | $24.3M | 7.51% | −160,000−6.4% | Reduced |
| Kynam Capital Management, LP | 3,114,132 | $32.2M | 2.10% | +811,960+35.3% | Added |
| Vanguard Group Inc | 3,298,504 | $34.1M | 0.00% | +355,179+12.1% | Added |
| BlackRock, Inc. | 4,400,296 | $45.5M | 0.00% | +230,334+5.5% | Added |
| BVF Inc | 5,750,683 | $59.5M | 2.00% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 7,648,268 | $79.2M | 9.06% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 8,963,500 | $92.8M | 18.78% | +3,197,410+55.5% | Added |
| Franklin Resources Inc | 0 | $0 | 0.00% | −1,416,036−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −1,121,138−100.0% | Sold out |
| Voss Capital, LLC | 0 | $0 | 0.00% | −221,473−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −56,777−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −56,736−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −56,486−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −48,652−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −32,669−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −28,389−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −26,263−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −26,234−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −13,942−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Wexford Capital LP | 0 | $0 | 0.00% | −5,317−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −1,365−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Colony Group, LLC | 0 | $0 | 0.00% | −3,498−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |
| Corton Capital Inc. | – | – | – | – | Not filed |
| Point72 (DIFC) Ltd | – | – | – | – | Not filed |